Literature DB >> 15745583

Priapism - etiology, pathophysiology and management.

C Van der Horst1, Henrik Stuebinger, Christoph Seif, Diethild Melchior, F J Martínez-Portillo, K P Juenemann.   

Abstract

The understanding of erectile physiology has improved the prompt diagnosis and treatment of priapism. Priapism is defined as prolonged and persistent erection of the penis without sexual stimulation and failure to subside despite orgasm. Numerous etiologies of this condition are considered. Among others a disturbed detumescence mechanism, which may due to excess release of contractile neurotransmitters, obstruction of draining venules, malfunction of the intrinsic detumescence mechanism or prolonged relaxation of intracavernosal smooth muscle are postulated. Treatment of priapism varies from a conservative medical to a drastic surgical approach. Two main types of priapism; veno-occlusive low flow (ischemic) and arterial high flow (non-ischemic), must be distinguished to choose the correct treatment option for each type. Patient history, physical examination, penile hemodynamics and corporeal metabolic blood quality provides distinction between a static or dynamic pathology. Priapism can be treated effectively with intracavernous vasoconstrictive agents or surgical shunting. Alternative options, such as intracavernous injection of methylene blue (MB) or selective penile arterial embolization (SPEA), for the management of high and low flow priapism are described and a survey on current treatment modalities is given.

Entities:  

Year:  2003        PMID: 15745583     DOI: 10.1590/s1677-55382003000500002

Source DB:  PubMed          Journal:  Int Braz J Urol        ISSN: 1677-5538            Impact factor:   1.541


  15 in total

1.  Management of priapism in adult men.

Authors:  Onyeanunam N Ekeke; Hannah E Omunakwe; Ndu Eke
Journal:  Int Surg       Date:  2015-03

Review 2.  Management of priapism: an update for clinicians.

Authors:  Helen R Levey; Robert L Segal; Trinity J Bivalacqua
Journal:  Ther Adv Urol       Date:  2014-12

3.  High flow priapism: diagnosis and treatment in pediatric population.

Authors:  Juan Pablo Corbetta; Víctor Durán; Carol Burek; Cristian Sager; Santiago Weller; Enrique Paz; Juan Carlos Lopez
Journal:  Pediatr Surg Int       Date:  2011-05-05       Impact factor: 1.827

4.  Persistently erected penis in a child for 6 months: A management dilemma.

Authors:  Sukanta Das; Dipak Ghosh; Akhilesh Agarwal; Suranjan Haldar
Journal:  J Indian Assoc Pediatr Surg       Date:  2008-01

5.  Critical urologic skills and procedures in the emergency department.

Authors:  Maria R Ramos-Fernandez; Roberto Medero-Colon; Lorraine Mendez-Carreno
Journal:  Emerg Med Clin North Am       Date:  2013-02       Impact factor: 2.264

6.  Increased adenosine contributes to penile fibrosis, a dangerous feature of priapism, via A2B adenosine receptor signaling.

Authors:  Jiaming Wen; Xianzhen Jiang; Yingbo Dai; Yujin Zhang; Yuxin Tang; Hong Sun; Tiejuan Mi; Prasad V Phatarpekar; Rodney E Kellems; Michael R Blackburn; Yang Xia
Journal:  FASEB J       Date:  2009-10-26       Impact factor: 5.191

7.  Embolization of high-flow priapism: technical aspects and clinical outcome from a single-center experience.

Authors:  Giuseppe De Magistris; Francesco Pane; Francesco Giurazza; Fabio Corvino; Milena Coppola; Antonio Borzelli; Mattia Silvestre; Francesco Amodio; Gianluca Cangiano; Enrico Cavaglià; Raffaella Niola
Journal:  Radiol Med       Date:  2019-12-10       Impact factor: 3.469

Review 8.  Priapism: new concepts in the pathophysiology and new treatment strategies.

Authors:  Trinity J Bivalacqua; Arthur L Burnett
Journal:  Curr Urol Rep       Date:  2006-11       Impact factor: 2.862

9.  Our experience in the treatment of priapism.

Authors:  Dmytro Vorobets; Oleg Banyra; Alexander Stroy; Alexander Shulyak
Journal:  Cent European J Urol       Date:  2011-06-02

10.  Priapism as the initial symptom of primary penile lymphoma: A case report.

Authors:  Zhaohua Gong; Ying Zhang; Hongjin Chu; Peiwen Lian; Liangming Zhang; Ping Sun; Jian Chen
Journal:  Oncol Lett       Date:  2014-08-28       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.